Skip to main content

From Challenge to Victory: TFS’s RWE EMA Success Story with a Pivotal Retrospective Study

Download our case study to:

Delve into how TFS leveraged vast US real-world data to secure EMA approval for an extended-release CNS drug, bypassing traditional costly trials.

Witness how our RWE team’s innovative design and AI-assisted analyses cut costs by 30 times and accelerated timelines, achieving non-inferiority and even superiority in key endpoints. Download now to uncover the RWE-driven breakthroughs that delivered this triumph.

"*" indicates required fields


Learn more about our related services and resources:

Phase IV-RWE

Contact Us:

We have the right people and the right solutions to help you on your path to success.

Let's Talk